0001193125-20-267232.txt : 20201009
0001193125-20-267232.hdr.sgml : 20201009
20201009162302
ACCESSION NUMBER:0001193125-20-267232
CONFORMED SUBMISSION TYPE:8-K/A
PUBLIC DOCUMENT COUNT:14
CONFORMED PERIOD OF REPORT:20201006
ITEM INFORMATION:Financial Statements and Exhibits
FILED AS OF DATE:20201009
DATE AS OF CHANGE:20201009
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME:NN INC
CENTRAL INDEX KEY:0000918541
STANDARD INDUSTRIAL CLASSIFICATION:BALL & ROLLER BEARINGS [3562]
IRS NUMBER:621096725
STATE OF INCORPORATION:DE
FISCAL YEAR END:1231
FILING VALUES:
FORM TYPE:8-K/A
SEC ACT:1934 Act
SEC FILE NUMBER:001-39268
FILM NUMBER:201233418
BUSINESS ADDRESS:
STREET 1:207 MOCKINGBIRD LANE
CITY:JOHNSON CITY
STATE:TN
ZIP:37604
BUSINESS PHONE:423-434-8300
MAIL ADDRESS:
STREET 1:207 MOCKINGBIRD LANE
CITY:JOHNSON CITY
STATE:TN
ZIP:37604
FORMER COMPANY:
FORMER CONFORMED NAME:NN BALL & ROLLER INC
DATE OF NAME CHANGE:19940203
8-K/A
1
d948551d8ka.htm
FORM 8-K/A
Form 8-K/A
NN INC true 0000918541 0000918541 2020-10-06 2020-10-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 9, 2020 (October 6, 2020)
NN, INC.
(Exact name of registrant as specified in its charter)
Delaware
000-23486
62-1096725
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
6210 Ardrey Kell Road
Charlotte, North Carolina
28277
(Address of principal executive offices)
(Zip Code)
(980) 264-4300
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
symbol
Name of each exchange
on which registered
Common Stock, par value $0.01
NNBR
The Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act:
None
(Title of class)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company. ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
This Amendment corrects certain typographical errors as well as errors in the calculation of certain Life Sciences Business Adjustments appearing in the unaudited pro forma condensed consolidated balance sheet of NN, Inc. (“NN”) as of June 30, 2020 and the unaudited pro forma condensed consolidated statements of operations of NN for the years ended December 31, 2017, December 31, 2018 and December 31, 2019 and the six months ended June 30, 2020, which were filed as Exhibit 99.2 to the Form 8-K filed with the Securities and Exchange Commission on October 8, 2020.
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
(b) Pro Forma Financial Information
NN’s unaudited pro forma condensed consolidated balance sheet as of June 30, 2020, and the unaudited pro forma condensed consolidated statements of operations for the years ended December 31, 2017, December 31, 2018 and December 31, 2019 and the six months ended June 30, 2020, and the notes related thereto, which have been updated to correct the errors noted above, are filed as Exhibit 99.1 and are hereby incorporated herein by reference.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 9, 2020
NN, INC.
By:
/s/ Matthew S. Heiter
Name:
Matthew S. Heiter
Title:
Senior Vice President, General Counsel
EX-99.1
2
d948551dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION
On October 6, 2020, NN, Inc. (the Company) completed the sale of its life sciences business (the Life Sciences
Business) to ASP Navigate Acquisition Corp. for total cash consideration of approximately $757.2 million. An additional earnout payment of up to $70 million may be payable to the Company during the year ending December 31, 2023,
if certain performance measures are achieved by the Life Sciences Business through December 31, 2022.
The unaudited pro forma
condensed consolidated balance sheet and the unaudited pro forma condensed consolidated statements of operations are derived from, and should be read in conjunction with, the historical financial statements and notes thereto of the Company, as
presented in its Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission (SEC) on March 16, 2020, and its Quarterly Report on
Form 10-Q for the quarter ended June 30, 2020, filed with the SEC on August 7, 2020.
The unaudited pro forma condensed consolidated financial statements have been prepared giving effect to the sale of the Companys Life
Sciences Business (the Transaction) as if the Transaction had occurred on June 30, 2020, for the unaudited pro forma condensed consolidated balance sheet and on January 1, 2017, for the unaudited pro forma condensed
consolidated statements of operations. The unaudited pro forma condensed consolidated financial statements have been prepared giving effect to the required use of proceeds to prepay a portion of the Companys credit facilities with all of the
net proceeds from the Transaction as if the prepayment of credit facilities had occurred on June 30, 2020, for the unaudited pro forma condensed consolidated balance sheet and on January 1, 2017, for the unaudited pro forma condensed
consolidated statements of operations.
The unaudited pro forma condensed consolidated financial statements are prepared in accordance
with Article 11 of Regulation S-X. The pro forma adjustments are described in the accompanying notes and are based upon information and assumptions available at the time of the filing of this Current Report on
Form 8-K.
The unaudited pro forma condensed financial statements do not purport to represent and
are not necessarily indicative of what the Companys actual financial position and results of operations would have been had the transaction occurred on the dates indicated. In addition, these unaudited pro forma condensed consolidated
financial statements should not be considered to be indicative of the Companys future financial performance.
The unaudited pro
forma condensed consolidated financial information includes information, statements, and assumptions that are or may be considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally may be identified by the use of words such as may, should, will, expect, anticipate, continue, estimate, project,
believe, plan or similar expressions. Statements that describe objectives, plans, or goals also are forward-looking statements. These forward-looking statements involve risks and uncertainties, and actual results may differ
materially from those contemplated by the forward-looking statements due to, among other, the risks and uncertainties described under the heading Risk Factors in the Companys Annual Report on Form
10-K for the fiscal year ended December 31, 2019, and in the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2020. For any
forward-looking statements contained herein, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and the Company undertakes no obligation to update
publicly or revise any forward-looking statements in light of the new information or future events, except as required by law.
1
Unaudited Pro Forma Condensed Consolidated Balance Sheet
As of June 30, 2020
(in thousands)
Consolidated
Historical
NN, Inc.
Life
Sciences
Business
Adjustments
Other
Pro Forma
Adjustments
Notes
Pro
Forma
Assets
Current assets:
Cash and cash equivalents
$
82,695
$
(12,158
)
$
14,289
(h
)
$
84,826
Accounts receivable, net
105,661
(37,370
)
68,291
Inventories
121,031
(51,950
)
69,081
Income tax receivable
17,458
17,458
Other current assets
15,477
(4,087
)
11,390
Total current assets
342,322
(105,565
)
14,289
251,046
Property, plant and equipment, net
344,073
(116,050
)
228,023
Operating lease
right-of-use assets
77,121
(24,825
)
52,296
Goodwill
196,467
(196,467
)
Intangible assets, net
306,577
(196,338
)
110,239
Investment in joint venture
22,104
22,104
Other non-current assets
7,350
(290
)
7,060
Total assets
$
1,296,014
$
(639,535
)
$
14,289
$
670,768
Liabilities, Preferred Stock, and Stockholders Equity
Current liabilities:
Accounts payable
$
43,751
$
(12,010
)
$
$
31,741
Accrued salaries, wages and benefits
33,335
(15,925
)
17,410
Income tax payable
867
(267
)
600
Current maturities of long-term debt
20,567
(219
)
20,348
Current portion of operating lease liabilities
7,068
(2,618
)
4,450
Other current liabilities
32,266
(5,961
)
26,305
Total current liabilities
137,854
(37,000
)
100,854
Deferred tax liabilities
73,691
(56,821
)
(b
)
16,870
Long-term debt, net of current portion
816,956
(884
)
(687,493
)
(a
)
128,579
Operating lease liabilities, net of current portion
79,712
(22,912
)
56,800
Other non-current liabilities
31,195
(4,983
)
26,212
Total liabilities
1,139,408
(65,779
)
(744,314
)
329,315
Series B convertible preferred stock
98,707
98,707
Total stockholders equity
57,899
(573,756
)
758,603
(d
)
242,746
Total liabilities, preferred stock, and stockholders equity
$
1,296,014
$
(639,535
)
$
14,289
$
670,768
See accompanying Notes to Unaudited Pro Forma Condensed Consolidated Financial Information.
2
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Six Months Ended June 30, 2020
(in thousands, except per share data)
Consolidated
Historical
NN, Inc.
Life Sciences
Business
Adjustments
Other
Pro Forma
Adjustments
Notes
Pro Forma
Net sales
$
350,165
(156,447
)
$
193,718
Cost of sales (exclusive of depreciation and amortization shown separately below)
267,630
(109,121
)
158,509
Selling, general and administrative expense
45,815
(14,024
)
(1,358
)
(c
)
30,433
Depreciation and amortization
46,385
(23,701
)
22,684
Goodwill impairment
239,699
(146,757
)
92,942
Other operating expense, net
4,174
3
4,177
Income (loss) from operations
(253,538
)
137,153
1,358
(115,027
)
Interest expense
35,773
345
(25,192
)
(e
)
10,926
Other expense, net
239
259
498
Income (loss) before benefit for income taxes
(289,550
)
136,549
26,550
(126,451
)
Benefit (provision) for income taxes
18,955
6,363
(5,575
)
(f
)
19,743
Share of net income from joint venture
656
656
Loss from continuing operations
$
(269,939
)
$
142,912
$
20,975
$
(106,052
)
Basic net loss per common share:
Loss from continuing operations per common share
$
(6.55
)
$
(2.66
)
Weighted average shares outstanding
42,154
42,154
Diluted net loss per common share:
Loss from continuing operations per common share
$
(6.55
)
$
(2.66
)
Weighted average shares outstanding
42,154
42,154
See accompanying Notes to Unaudited Pro Forma Condensed Consolidated Financial Information.
3
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2019
(in thousands, except per share data)
Consolidated
Historical
NN, Inc.
Life Sciences
Business
Adjustments
Other
Pro Forma
Adjustments
Notes
Pro
Forma
Net sales
$
847,451
(359,732
)
$
487,719
Cost of sales (exclusive of depreciation and amortization shown separately below)
641,639
(250,952
)
390,687
Selling, general and administrative expense
103,223
(34,330
)
68,893
Depreciation and amortization
91,846
(46,950
)
44,896
Restructuring and integration expense, net
(12
)
(12
)
Other operating expense (income), net
866
(20
)
846
Income (loss) from operations
9,889
(27,480
)
(17,591
)
Interest expense
57,155
498
(46,935
)
(e
)
10,718
Loss on extinguishment of debt and write-off of debt
issuance costs
3,293
(2,741
)
(g
)
552
Other expense (income), net
1,140
(178
)
962
Loss before benefit for income taxes
(51,699
)
(27,800
)
49,676
(29,823
)
Benefit (provision) for income taxes
3,277
7,728
(10,432
)
(f
)
573
Share of net income from joint venture
1,681
1,681
Loss from continuing operations
$
(46,741
)
$
(20,072
)
$
39,244
$
(27,569
)
Basic net loss per common share:
Loss from continuing operations per common share
$
(1.13
)
$
(0.67
)
Weighted average shares outstanding
42,030
42,030
Diluted net loss per common share:
Loss from continuing operations per common share
$
(1.13
)
$
(0.67
)
Weighted average shares outstanding
42,030
42,030
See accompanying Notes to Unaudited Pro Forma Condensed Consolidated Financial Information.
4
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2018
(in thousands, except per share data)
Consolidated
Historical
NN, Inc.
Life Sciences
Business
Adjustments
Other
Pro Forma
Adjustments
Notes
Pro Forma
Net sales
$
770,657
(248,173
)
$
522,484
Cost of sales (exclusive of depreciation and amortization shown separately below)
589,181
(177,497
)
411,684
Selling, general and administrative expense
93,583
(20,927
)
72,656
Acquisition related costs excluded from selling, general and administrative expense
5,871
(5,763
)
108
Depreciation and amortization
71,128
(28,102
)
43,026
Goodwill impairment
182,542
182,542
Restructuring and integration expense, net
2,127
(1,438
)
689
Other operating expense, net
6,089
737
6,826
Loss from operations
(179,864
)
(15,183
)
(195,047
)
Interest expense
61,243
49
(52,671
)
(e)
8,621
Loss on extinguishment of debt and write-off of debt
issuance costs
19,562
(19,562
)
(g)
Other expense (income), net
1,341
675
2,016
Loss before benefit for income taxes
(262,010
)
(15,907
)
72,233
(205,684
)
Benefit (provision) for income taxes
13,413
3,802
(15,169
)
(f)
2,046
Share of net loss from joint venture
(14,390
)
(14,390
)
Loss from continuing operations
$
(262,987
)
$
(12,105
)
$
57,064
$
(218,028
)
Basic net loss per common share:
Loss from continuing operations per common share
$
(8.30
)
$
(6.88
)
Weighted average shares outstanding
31,678
31,678
Diluted net loss per common share:
Loss from continuing operations per common share
$
(8.30
)
$
(6.88
)
Weighted average shares outstanding
31,678
31,678
See accompanying Notes to Unaudited Pro Forma Condensed Consolidated Financial Information.
5
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2017
(in thousands, except per share data)
Consolidated
Historical
NN, Inc.
Life Sciences
Business
Adjustments
Other
Pro Forma
Adjustments
Notes
Pro
Forma
Net sales
$
619,793
(98,329
)
$
521,464
Cost of sales (exclusive of depreciation and amortization shown separately below)
460,414
(64,949
)
395,465
Selling, general and administrative expense
74,112
(8,504
)
65,608
Acquisition related costs excluded from selling, general and administrative expense
344
344
Depreciation and amortization
52,406
(12,091
)
40,315
Restructuring and integration expense, net
386
386
Other operating expense, net
351
351
Income (loss) from operations
31,780
(12,785
)
18,995
Interest expense
52,085
52
(24,737
)
(e
)
27,400
Loss on extinguishment of debt and write-off of debt
issuance costs
42,087
(36,460
)
(g
)
5,627
Derivative gain on change in interest rate swap fair value
(101
)
(101
)
Other expense (income), net
(2,084
)
(2,084
)
Loss before benefit for income taxes
(60,207
)
(12,837
)
61,197
(11,847
)
Benefit (provision) for income taxes
79,545
(8,013
)
(21,419
)
(f
)
50,113
Share of net income from joint venture
5,211
5,211
Income from continuing operations
$
24,549
$
(20,850
)
$
39,778
$
43,477
Basic net income per common share:
Income from continuing operations per common share
$
0.89
$
1.58
Weighted average shares outstanding
27,433
27,433
Diluted net income per share:
Income from continuing operations per common share
$
0.89
$
1.58
Weighted average shares outstanding
27,755
27,755
See accompanying Notes to Unaudited Pro Forma Condensed Consolidated Financial Information.
6
NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION
(In thousands, except per share information)
Note 1. Basis of Presentation
The
historical consolidated financial statements have been adjusted in the pro forma condensed consolidated financial statements to give effect to pro forma events that are (1) directly attributable to the Transaction, (2) factually
supportable and (3) with respect to the pro forma condensed consolidated statements of operations, expected to have a continuing impact on the Company.
The pro forma condensed consolidated financial statements do not necessarily reflect what the consolidated Companys financial condition
or results of operations would have been had the Transaction occurred on the dates indicated. They also may not be useful in predicting the future financial condition and results of operations of the Company. The actual financial position and
results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors.
The condensed
consolidated pro forma financial information does not reflect the realization of any expected cost savings from the sale of the Life Sciences Business.
Note 2. Disposition of Life Sciences Business
The estimated net proceeds and gain on the sale of the Life Sciences Business, based on the historical book balances of the Life Sciences
Business as of June 30, 2020, are as follows:
Proceeds from sale (1)
$
757,225
Net assets sold as of June 30, 2020
(573,756
)
Currency translation adjustment in accumulated other comprehensive income as of June 30,
2020
(8,615
)
Transaction costs (2)
(17,344
)
Estimated gain on sale (3)
$
157,510
(1)
Only cash proceeds are considered in the estimated gain calculation. The potential earnout payment of up to
$70 million will be recognized if the payment becomes probable.
(2)
Transaction costs include accounting, tax, valuation, consulting, legal and investment banking fees related to
the sale of the Life Sciences Business, including approximately $1.4 million of Transaction costs expensed prior to June 30, 2020.
(3)
Using facts and circumstances available as of the date of this Current Report on Form 8-K, the Company expects no taxable gain on sale.
Note 3. Pro Forma Adjustments
The following are descriptions of the pro forma adjustments related to the Transaction:
(a)
Reflects the allocation of net proceeds from the Transaction to prepay term loans under the Companys
credit facility. Collectively, the Companys credit facility includes a senior secured term loan with an outstanding principal balance of $523.4 million as of June 30, 2020, an incremental term loan with an outstanding principal
balance of $251.3 million as of June 30, 2020, and a senior secured revolver with an outstanding principal balance of $62.5 million as of June 30, 2020. The Companys credit agreement, as amended on August 22, 2020,
requires all net proceeds (as defined by the credit agreement) from the Transaction to be applied as a prepayment of the senior secured term loan and the incremental term loan. The pro forma adjustment to debt includes the following amounts:
7
As of
June 30, 2020
Net proceeds used to pay down credit facilities
$
(700,000
)
Accelerated amortization of debt issuance costs
12,507
Pro forma adjustment to debt
$
(687,493
)
(b)
Represents the net deferred income tax liability related to the Life Sciences Business.
(c)
Reflects the removal of Transaction costs that were incurred prior to June 30, 2020, because they will not
have a continuing impact on the Company.
(d)
The unaudited pro forma condensed consolidated statements of operations exclude the estimated gain resulting
from the sale of the Life Sciences Business. This estimated gain will not have a continuing impact on the Company and is therefore reflected as a pro forma adjustment to stockholders equity in the unaudited pro forma condensed consolidated
balance sheet. The pro forma adjustment to stockholders equity includes the following amounts:
As of
June 30, 2020
Pro forma adjustment to debt
$
687,493
Estimated cash on Life Sciences closing balance sheet
14,289
Deferred income taxes
56,821
Pro forma adjustment to stockholders equity
$
758,603
(e)
Reflects the change in estimated interest expense and amortization of debt issuance costs incurred from the
Companys credit facility as a result of the requirement for the Company to use all net proceeds from the Transaction to prepay approximately $700.0 million on its term loans. The pro forma adjustment to interest expense is presented as if
the Transaction and prepayment of debt had occurred on January 1, 2017. Amortization of debt issuance costs for the year ended December 31, 2017, includes $19.1 million of accelerated amortization on the assumed prepayment date of
January 1, 2017. The pro forma adjustment to interest expense includes the following:
Six Months Ended
June 30, 2020
Year Ended December 31,
2019
2018
2017
Interest on debt
$
(22,745
)
$
(43,550
)
$
(49,049
)
$
(40,700
)
Amortization of debt issuance costs
(2,447
)
(3,385
)
(3,622
)
15,963
Pro forma adjustment to interest expense
$
(25,192
)
$
(46,935
)
$
(52,671
)
$
(24,737
)
(f)
Represents the estimated income tax effect, using a federal statutory rate of 21% for 2020, 2019, and 2018, and
35% for 2017, related to the change in write-off of unamortized debt issuance costs and changes in interest expense. The effective tax rate of the Company after the Transaction may differ from what is
presented in the unaudited pro forma condensed consolidated financial statements as a result of different tax jurisdictions.
(g)
Represents the loss on extinguishment of debt and write-off of
unamortized debt issuance costs related to debt modifications as if the proceeds of the Transaction had been used for the required prepayment of the Companys term loans as of January 1, 2017.
(h)
Represents estimated cash on closing balance sheet that was factored into the calculation of proceeds from
sale.
8
EX-101.SCH
3
nnbr-20201006.xsd
XBRL TAXONOMY EXTENSION SCHEMA
100000 - Document - Document and Entity Information
link:calculationLink
link:presentationLink
link:definitionLink
EX-101.LAB
4
nnbr-20201006_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
Cover [Abstract]
Cover [Abstract]
Entity Registrant Name
Entity Registrant Name
Amendment Flag
Amendment Flag
Entity Central Index Key
Entity Central Index Key
Document Type
Document Type
Document Period End Date
Document Period End Date
Entity Incorporation State Country Code
Entity Incorporation State Country Code
Entity File Number
Entity File Number
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, City or Town
Entity Address, State or Province
Entity Address, State or Province
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Security 12b Title
Security 12b Title
Trading Symbol
Trading Symbol
Security Exchange Name
Security Exchange Name
Written Communications
Written Communications
Soliciting Material
Soliciting Material
Pre Commencement Tender Offer
Pre Commencement Tender Offer
Pre Commencement Issuer Tender Offer
Pre Commencement Issuer Tender Offer
Entity Emerging Growth Company
Entity Emerging Growth Company
Amendment Description
Amendment Description
EX-101.PRE
5
nnbr-20201006_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
GRAPHIC
6
g948551g1008224320194.jpg
GRAPHIC
begin 644 g948551g1008224320194.jpg
M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$!
M 0$! 0 $" P0%!@'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ Z4
ME4]0U*WT^)6E)9W.(XD&7YPRS"*=D?1"^(M,)P
M\[Q?]=8F3^8K0M[JWNDWV\TS)BA'8O_$WX=*:79>-?%]QI5S
M):6TN[5Y5Q<70'RVZG_EG'_4UY//"$?B;09%A55
MOX,R0/CJ>ZGV-?.LB-%(T;J4D1BKJ1R"*]O SA*'NZ,\7&PG&?O/058Y'&4C
M=AZJI-#12*,O%(J^I4BO;_@XB/X4N"R*3]I;J/85H_%&*-/!4K*B@_:(>@Q_
M&*F6-:J^SL.."O2]IE8*4^62LBJF7N,.:+U/$M,U2\
MT>]2\L)WAF3NIX8>A'<5[/X0\5)?61U"WB,:*0+ZT4?*A/\ RTC]O45X:.*^
MA/AA&C> ++**=Q*K'J*@I-$X!R*VU%W11UB\;3]'N[M "\49*CU/:FZ+;?9
M=(M8C]_8&?\ WCR?U-0>)/\ D#[>S3Q*?H7%:H XI_9)^T./2O%_BQX0^RW
M/_"0V4?[J4@72@?=;LWX]Z];DU.VCU6/37D N)8C*BG^)0G&K!Q."^#?\ R*5Q_P!?3?R%:7Q2_P"1(E_Z^(?_
M $,58\"^'9O#-C?6$GS1_:F>%_[R$<57^*7_ ")$O_7S#_Z&*T\?^X/Y55CU.VEU2?3ED'VJ%%D9#_=/
M0BN9IG5=(\/^)WA+^P=7_M&TC_XE]XQ.!TCD[CZ'K7I7PN_Y)_8?5_\ T(UT
M6M:-:ZYH]QIUTN8I4P#W4]B/5;BUAF4_+(BN/Q&:?+&D
MT3Q2*&1U*L#W!K*T!S%;RZ?(3YMFYCY[IU4_E_*GO$6TCSGXM:C]/_
M '!_*O&_'NN7'ASXGV^HVY/[N!!(O]]3U%>R0?\ 'O'_ +@_E7@WQ?X\;#_K
MV2NC!14JO*^S.?&R$D]/H?YU[?6&(HNC/E9OAZRJPYD9.N$22Z;;YYDNU;\%!;^
ME:OZUEADO/$.T+D647+=M[]OK@?K6MBLGLD:1W;"L758Y+*[CU>W0ML79>=N>]?17
MB#PO!/9S0O:FYTR0EGMU^_ W]^/^HKQ_7/ ]_IRO=V!_M'3P?]9$/GC]G7J#
M7LX3$0Y%#8\;%X>?.Y[G1>'_ (N2Z5HT%C?6#W='@D$8(ZCTI*V^J4>;F2,?K=7EY&SUY/C7"B*O]
MBRG: /\ 7#_"N!\8^)%\5:W_ &BELUN/+";&;/2L#!I\$$UU,L-O$\LK)J55RO49N*D,&*LIR&!P0:][\)>,-1U#PU'/>V+"8 0P2;
MN;I_4+U [DUPOA[X?%)XIM<1GD/,6GQ',C_[Y_A6O7](T8VI2YNEC^T!-D<<
M8Q' O]U1_6N'&UJ?&SVUS_ ,]H3@GZCH?QK3HH3ML)I/QY;:_#33$;(T*[D/\ T]7@"_DN:ZG3?";6:;(5M=.B[K9Q_.?JYY_*NJH%
J*6(G+=CCAZ<>A4LM,M=/0BWB"LWWW/+-]3U-6\4M%8MW-[6"BBB@#__9
end
XML
7
d948551d8ka_htm.xml
IDEA: XBRL DOCUMENT
0000918541
2020-10-06
2020-10-06
NN INC
true
0000918541
8-K/A
2020-10-06
DE
000-23486
62-1096725
6210 Ardrey Kell Road
Charlotte
NC
28277
(980)
264-4300
Common Stock, par value $0.01
NNBR
NASDAQ
false
false
false
false
false
This Amendment corrects certain typographical errors as well as errors in the calculation of certain Life Sciences Business Adjustments appearing in the unaudited pro forma condensed consolidated balance sheet of NN, Inc. (“NN”) as of June 30, 2020 and the unaudited pro forma condensed consolidated statements of operations of NN for the years ended December 31, 2017, December 31, 2018 and December 31, 2019 and the six months ended June 30, 2020, which were filed as Exhibit 99.2 to the Form 8-K filed with the Securities and Exchange Commission on October 8, 2020.
XML
8
R1.htm
IDEA: XBRL DOCUMENT
v3.20.2Document and Entity Information
Oct. 06, 2020
Common Stock, par value $0.01
This Amendment corrects certain typographical errors as well as errors in the calculation of certain Life Sciences Business Adjustments appearing in the unaudited pro forma condensed consolidated balance sheet of NN, Inc. (“NN”) as of June 30, 2020 and the unaudited pro forma condensed consolidated statements of operations of NN for the years ended December 31, 2017, December 31, 2018 and December 31, 2019 and the six months ended June 30, 2020, which were filed as Exhibit 99.2 to the Form 8-K filed with the Securities and Exchange Commission on October 8, 2020.
- Definition
Description of changes contained within amended document.
+ References
No definition available.
+ Details
Name:
dei_AmendmentDescription
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
EXCEL
9
Financial_Report.xlsx
IDEA: XBRL DOCUMENT
begin 644 Financial_Report.xlsx
M4$L#!!0 ( .""25$'04UB@0 +$ 0 9&]C4')OQLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQJ=0U[R;UEA_6\#MI7E!+ P04
M " #@@DE1@\)_CNT K @ $0 &1O8U!R;W!S+V-O&ULS9+!
M2L0P$(9?17)O)VUAP=#M1?&D(+B@> N3V=U@TX1DI-VWMXV[740?P&-F_GSS
M#4R+0:&/]!Q]H,B6TLWD^B$I#%MQ9 X*(.&1G$[EG!CFYMY'IWE^Q@,$C1_Z
M0%!+N0%'K(UF#0NP""M1=*U!A9$T^WC&&USQX3/V&680J"=' R>HR@I$MTP,
MIZEOX0I88$S1I>\"F968JW]B
WI\R>L6=DBL
M!Z3Y5[**3X&VXC+YM;F[WSV(KI:U+"I9R-M=M5%UHZ1\7UQ_^%V%G3=V;_^Q
M\46P:^'7771?4$L#!!0 ( .""25&97)PC$ 8 )PG 3 >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%[R:0S>IU].LYKE']I
MJP&G[;N;SY/\3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/FE1M'V5;SOX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
MC
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!
M8/+]U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @
MX())40]4ND%A!0 _A( !@ !X;"]W;W)K&E37)'2+JQMI2%;+W;;C\(6V"MMN5)ID6F."[:0OOI(C_35R\56R*\J8DS#+HE3==F*M,[>=KLJB%A"54=D
M+,5?UD(F5..KW'15)AD-;:$D[A+/&W03RM/6U85-6\BK"Y'KF*=L(4'E24+E
M_IK%8GO9\EN/"7=\$VF3T+VZR.B&+9G^(UM(?.N6*B%/6*JX2$&R]65KXK^]
M)N>F@,WQ)V=;]>093%-60GPU+[/PLN49(A:S0!L)BE\/;,KBV"@AQW\'T599
MIRGX]/E1_;UM/#9F116;BO@+#W5TV1JU(&1KFL?Z3FQ_98[0$4\*C(X5((&JBLM02?^583E_=B"#'3M9 TQ!N4\WU'F9I$6WLM8NNQDI,UFYP
M$+PN!,D1P\>!?92D!2 A*KUSNB-Q4/3,+?DY72$D/XCT.R
M5TKVK&3_B.2AF7=LPXTH-GY.$U;75+?.? ZS^=0!U"^!^DZA"48@M%%X']--
M'8B[O)8Y-QXSF.?)
MBLDZ$+WZL\SSN%Z)[N8!9B2/F:!T6G'>=KD!R0,]\;#X;D
MW$7XQ)7]4P@G82B94NW'!_B(^>!S6AO*!LD!\3V82-39XZ2.8[@3-'3!5@[M
MD^^"G9HW(>%>;.L7$+?N[[MM^R7:0BB-OOL7SXY.UP9%,B+#H8NM6@I\MX/;&$YPGWYW-:O5@+?;>!+%N32=)!/
M5G#/=5S?06Z1J4@2:],B^-J&C$IXH''.X">OX[F63;]:%7RW>]]+&O)T \M]
MLA)Q+:);8#Z_OG.15"N [[;OLL-N=T%$TPT[NN-J$)I/EC>3WUW;RFH1(&['
M_H) FJ5@XI"GAP5 U3$U"*UIK%Q>12K7)VZ+7HJ8!UR;F'U"EY*K$[3LYR=MO$R8W)IZ_H(*.#'-&T]H==8-@(UIE[<3MS-5IXX:I0/+LV$&O
M0>9V$B:1=SX-Y-22 54P=9L/O#[D&)R1@PP
M3Y#'Q2Y,K$N1CWS-8!EP$V@%U[E""-P'35$QHH-NRJJ-V6MXAX;A9V$
M$GC.8#C,<>GF_J]8?M;Y)&%N5EZK@$5'P'N-[HZ%'S63O:L,4P11@;G%AK
MW*F'IK6WNXBON(;QN$- "ZMC[D( SU2'7%N.H]JD'RR>8Y3L5&ULU57;BM1 $/V5IC_ GD1V04D"*BP(
M*@L[#[YVDDK2T#J3YV^3M;C).&I T R*JG[
MG':(]BUC?=6!XOTK8T'[3&.M5&;0F-,39476&+TSKVDD?"E70"Y.;E,;5X+8V"5VI(I/0!#M.M%WXHK$L)!&-\D$M
M><GSVL(Y; RU8@Y5/8PJ_-E?;8D+@7'^NP#21,=0V]H26,,A$$_:-:U#[(
MWOV1++'B8O#]X&>C9_QM, B/#AHQSGALMOZWU)/;ZMQ:.;V3HM4*XMQ_N6&1
M\74PQ6]NJ ;2\)#F-,OX7V5NP=2#D*BT OJ1%V#?G%/O3SR
MTC_@5_J^OH:Q+/6S*G>_P9:C&H-UO58UB7I6J//X7W*+F?&^[_$L4/4$L#
M!!0 ( .""25&7BKL
-8?20$3;8T.P6BP^0"X99K>]9!:G
MH_ 0 / ( \ !X;"]W;W)K8F]O
M:RYX;6R-49:EL@9OTDUL(,BDBN0-2TN'+#4$
MQJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&& 3L@!W".?W.NU:=,.$>'?)WH?NW
M ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.%7HR#'9 C.4?>-N)_#3[U"-L]A]&
MA!1ZE@MAA92XW^CYC6@\@2P/73>TFH=>Y!L/?P
M&HT=S8\?M_P!4$L#!!0 ( .""25$D'INBK0 /@! : >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S
M(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.
MXS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*/Y#='7=:7PX_;(X\ \PO%WH
MJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W
M1:[-XPFNWPQP>'3^ 5!+ P04 " #@@DE199!YDAD! #/ P $P %M#
M;VYT96YT7U1YO,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBN
MM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F
MI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!
M9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8
MYL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0 ( .""25$'
M04UB@0 +$ 0 " 0 !D;V-0&UL
M4$L! A0#% @ X())48/"?X[M *P( !$ ( !KP
M &1O8U!R;W!S+V-O&UL4$L! A0#% @ X())49E&PO=V]R
M:W-H965T&UL4$L! A0#% @ X())48.II0/4 0 ,@8
M T ( !HPT 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% @ X())420>FZ*M ^ $ !H
M ( !]Q$ 'AL+U]R96QS+W=O9(9 0 SP, !, ( !W!( %M#
G;VYT96YT7U1Y
XML
10
Show.js
IDEA: XBRL DOCUMENT
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
XML
11
report.css
IDEA: XBRL DOCUMENT
/* Updated 2009-11-04 */
/* v2.2.0.24 */
/* DefRef Styles */
..report table.authRefData{
background-color: #def;
border: 2px solid #2F4497;
font-size: 1em;
position: absolute;
}
..report table.authRefData a {
display: block;
font-weight: bold;
}
..report table.authRefData p {
margin-top: 0px;
}
..report table.authRefData .hide {
background-color: #2F4497;
padding: 1px 3px 0px 0px;
text-align: right;
}
..report table.authRefData .hide a:hover {
background-color: #2F4497;
}
..report table.authRefData .body {
height: 150px;
overflow: auto;
width: 400px;
}
..report table.authRefData table{
font-size: 1em;
}
/* Report Styles */
..pl a, .pl a:visited {
color: black;
text-decoration: none;
}
/* table */
..report {
background-color: white;
border: 2px solid #acf;
clear: both;
color: black;
font: normal 8pt Helvetica, Arial, san-serif;
margin-bottom: 2em;
}
..report hr {
border: 1px solid #acf;
}
/* Top labels */
..report th {
background-color: #acf;
color: black;
font-weight: bold;
text-align: center;
}
..report th.void{
background-color: transparent;
color: #000000;
font: bold 10pt Helvetica, Arial, san-serif;
text-align: left;
}
..report .pl {
text-align: left;
vertical-align: top;
white-space: normal;
width: 200px;
white-space: normal; /* word-wrap: break-word; */
}
..report td.pl a.a {
cursor: pointer;
display: block;
width: 200px;
overflow: hidden;
}
..report td.pl div.a {
width: 200px;
}
..report td.pl a:hover {
background-color: #ffc;
}
/* Header rows... */
..report tr.rh {
background-color: #acf;
color: black;
font-weight: bold;
}
/* Calendars... */
..report .rc {
background-color: #f0f0f0;
}
/* Even rows... */
..report .re, .report .reu {
background-color: #def;
}
..report .reu td {
border-bottom: 1px solid black;
}
/* Odd rows... */
..report .ro, .report .rou {
background-color: white;
}
..report .rou td {
border-bottom: 1px solid black;
}
..report .rou table td, .report .reu table td {
border-bottom: 0px solid black;
}
/* styles for footnote marker */
..report .fn {
white-space: nowrap;
}
/* styles for numeric types */
..report .num, .report .nump {
text-align: right;
white-space: nowrap;
}
..report .nump {
padding-left: 2em;
}
..report .nump {
padding: 0px 0.4em 0px 2em;
}
/* styles for text types */
..report .text {
text-align: left;
white-space: normal;
}
..report .text .big {
margin-bottom: 1em;
width: 17em;
}
..report .text .more {
display: none;
}
..report .text .note {
font-style: italic;
font-weight: bold;
}
..report .text .small {
width: 10em;
}
..report sup {
font-style: italic;
}
..report .outerFootnotes {
font-size: 1em;
}
XML
12
FilingSummary.xml
IDEA: XBRL DOCUMENT
3.20.2
html
1
95
1
false
0
0
false
0
false
false
R1.htm
100000 - Document - Document and Entity Information
Sheet
http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation
Document and Entity Information
Cover
1
false
false
All Reports
Book
All Reports
d948551d8ka.htm
d948551dex991.htm
nnbr-20201006.xsd
nnbr-20201006_lab.xml
nnbr-20201006_pre.xml
g948551g1008224320194.jpg
http://xbrl.sec.gov/dei/2019-01-31
true
false
JSON
15
MetaLinks.json
IDEA: XBRL DOCUMENT
{
"instance": {
"d948551d8ka.htm": {
"axisCustom": 0,
"axisStandard": 0,
"contextCount": 1,
"dts": {
"inline": {
"local": [
"d948551d8ka.htm"
]
},
"labelLink": {
"local": [
"nnbr-20201006_lab.xml"
],
"remote": [
"https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
]
},
"presentationLink": {
"local": [
"nnbr-20201006_pre.xml"
]
},
"referenceLink": {
"remote": [
"https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
]
},
"schema": {
"local": [
"nnbr-20201006.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
"http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
"http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
"https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
"http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd"
]
}
},
"elementCount": 24,
"entityCount": 1,
"hidden": {
"http://xbrl.sec.gov/dei/2019-01-31": 3,
"total": 3
},
"keyCustom": 0,
"keyStandard": 95,
"memberCustom": 0,
"memberStandard": 0,
"nsprefix": "nnbr",
"nsuri": "http://www.nninc.com/20201006",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"p",
"div",
"div",
"body",
"html"
],
"baseRef": "d948551d8ka.htm",
"contextRef": "duration_2020-10-06_to_2020-10-06",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "100000 - Document - Document and Entity Information",
"role": "http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation",
"shortName": "Document and Entity Information",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"div",
"div",
"body",
"html"
],
"baseRef": "d948551d8ka.htm",
"contextRef": "duration_2020-10-06_to_2020-10-06",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 0,
"tag": {
"dei_AmendmentDescription": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Description of changes contained within amended document.",
"label": "Amendment Description",
"terseLabel": "Amendment Description"
}
}
},
"localname": "AmendmentDescription",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "stringItemType"
},
"dei_AmendmentFlag": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag",
"terseLabel": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code",
"terseLabel": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CoverAbstract": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Cover page.",
"label": "Cover [Abstract]",
"terseLabel": "Cover [Abstract]"
}
}
},
"localname": "CoverAbstract",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"xbrltype": "stringItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
"label": "Document Period End Date",
"terseLabel": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "dateItemType"
},
"dei_DocumentType": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type",
"terseLabel": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "submissionTypeItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One",
"terseLabel": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town",
"terseLabel": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code",
"terseLabel": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province",
"terseLabel": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r5"
],
"lang": {
"en-US": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key",
"terseLabel": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r5"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company",
"terseLabel": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number",
"terseLabel": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation State Country Code",
"terseLabel": "Entity Incorporation State Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r5"
],
"lang": {
"en-US": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name",
"terseLabel": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r5"
],
"lang": {
"en-US": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number",
"terseLabel": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "employerIdItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number",
"terseLabel": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_PreCommencementIssuerTenderOffer": {
"auth_ref": [
"r2"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
"label": "Pre Commencement Issuer Tender Offer",
"terseLabel": "Pre Commencement Issuer Tender Offer"
}
}
},
"localname": "PreCommencementIssuerTenderOffer",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_PreCommencementTenderOffer": {
"auth_ref": [
"r3"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
"label": "Pre Commencement Tender Offer",
"terseLabel": "Pre Commencement Tender Offer"
}
}
},
"localname": "PreCommencementTenderOffer",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r0"
],
"lang": {
"en-US": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Security 12b Title",
"terseLabel": "Security 12b Title"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r1"
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Security Exchange Name",
"terseLabel": "Security Exchange Name"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_SolicitingMaterial": {
"auth_ref": [
"r4"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
"label": "Soliciting Material",
"terseLabel": "Soliciting Material"
}
}
},
"localname": "SolicitingMaterial",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_TradingSymbol": {
"auth_ref": [],
"lang": {
"en-US": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol",
"terseLabel": "Trading Symbol"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "tradingSymbolItemType"
},
"dei_WrittenCommunications": {
"auth_ref": [
"r6"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
"label": "Written Communications",
"terseLabel": "Written Communications"
}
}
},
"localname": "WrittenCommunications",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.nninc.com//20201006/taxonomy/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
}
},
"unitCount": 0
}
},
"std_ref": {
"r0": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r1": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r2": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "13e",
"Subsection": "4c"
},
"r3": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "14d",
"Subsection": "2b"
},
"r4": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "14a",
"Subsection": "12"
},
"r5": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r6": {
"Name": "Securities Act",
"Number": "230",
"Publisher": "SEC",
"Section": "425"
}
},
"version": "2.1"
}
ZIP
16
0001193125-20-267232-xbrl.zip
IDEA: XBRL DOCUMENT
begin 644 0001193125-20-267232-xbrl.zip
M4$L#!!0 ( .""25%B_3)]&Q .!I / 9#DT.#4U,60X:V$N:'1M
M[5WKR4[
MP/WUURT_P&">@3 WFZG=!"Q9:K6Z?_W0(]?_& \M\L*$Y(Y]D]&S^0QAMN&8
MW.[?9'ROIY4SY!^W/_]T/?"@(E2V9=5D_"8S\#RWFLN-N\+*2F9D^\Y+#@IR
MA;Q>T?*Z5M0S875?:M[$93)^IT=E-^N(?BXJ27G)=FS;'\:OC$:CK.H*7S,]
MDI9#%%
M=E^GUIU5SGJ"V[#EB
M2#V0'&SI7,L7M,+%3",:R$6BH4A.UK53GA$$R8UT88,"K*XGY0:K\%6&WLYU3#)X7NYL&U"R'77,2>WUR9_
M(=*;6.PF8W+I6G2"2L,RM^2:CZM8G8GP,S=-9@>?H4HST!C"S9O,)U7T.RCN
M[W4;B)RT6)]+G!2O28= D T_H0/&J^GEBN"QUV(]J.4+-8N_HSYH>E[+7_SN
M.3/?,K?-)FDT:]>Y!"4+E$T[O1LRVX3_O0>+]K?NS1,^6]=7*A=JT*.@5L,V
MV?@SFRRR8:'"EI3EX5]%+Y^7]$7Z^JQVREMT9O3LBFMYI*Z44GPYMZ]FZEJLYUT-J>AS6\//54)]SXF>
M"-X?A(^P.3=J#&V -F"J%!P/-V["NXWG.4#WI.@)(CY[H[IA(Q^(F
M^26O_F5N__Z+?I&_NLZYRSHJKN^HL'-',\V6H!&R. #2@ZG1)/\OJ^KE^'N/
M#KDUJ7;XD$G29"/2;""827E8IU"I@GFQDV!F\U M*9M7@9(6]%\7
M![^ADDX'$V%$VGQ=O)%,/3RUOI!KZ5([AJ$!]Y@&3PP&IG,DJ NF9)D+<>\8
M/GH0,P[6YG8Z=-^2)OHZA\3) $)V 8#ANE%\M0B^OF)>7I\*I\>2.=3GS?=[4.@6*]4BPM
MI_.M9A=]'^+T2(NYCO#(2?2=4?!]F/0(>X&:1*AB9IY6R9/A.5UP\BIG!)6;
MG*P%BV?E4=4#1VM;U"!!/'N3@1BX:D(#0WA]8-+)!$AD-G ZI.7^9E
MX1U9TI'E-7Q9IFB+\IO"-HC'^;!/I#!N,OU*J7Q^KOS:T?N15
M@)7?QX!.ZF-J>$I[4?]%3#"ADDB7&1B=F83;A'N2& .(L)AX5ZZ#*Q=FP&C7
M8L1@EH5>FDHFYS/JNTM-,_H>=A4.U7 LB[J25:,/JR5D1IS0S0R8 5KX:\BZ
M:CXDLYJ/8D\D3 2_S&1(6RS]BMD(SYPK?6'"XP:U0N8& TZM&;93V**=B.;T
M5^8;A!\A[2*JXM(^T[J"T6^83.8FJ](7!P1D8\;I:NJ2_9(982()::HJ.2)S
M8P&9 IGH65>=UV Q:XYO>V)2,P5
MS@MVB^;WGEET!)9XJ5^_J1A$,K]0_R \W#D""IC\P"T&9>!W[)*MU K%4OEB
M*<=^9,9UZ+@1YOH,Q:D=N7A1@$^5B\O"^09L/(2VE_>D[+M:_;UD TX4/A!'
MD"=O #[T/WW!I=IIHS''(IOX=90>0C
M@=+^A2>DD6UEVUE2'[J6,V'BZ+.2Q%32=++3R5'H!S_0B_Q_=4I5C//NE1[1
M*P4#C3-MWV2*NRO??D+5-2[&G6D*)F7XZQ&B17T']T+/DSL!+4S(9Y!IH(Z:
MBY[&[EK_EIRHP
MV#E.8,X:7IZ$W,+DE2M UKA++8.1&8G(3VIE/.GBYMW=HXU'QU@^_/ L7+N3AF8JM!GQ'0 LM'7XQ0F!G@@9*KW9><
M]D,Z;N6#6#/(- N%\/"5!NH+1/O2:5)_PPDBGRAXAOSR./CPD&6[S0"
MWM[1[:]R=(\P@B;$B,>/8&/W1WD^[Y'=,2([3/ R4$*43>JZPG$%QP7AKC/&
M.!P?JX-W:S,Q9>USM)6MQRW,.'!).!Z_,T$Y0"+.@>9>5[GB\'$:4BZ&KG.A[69>R[P?$G10
M^G7>?0PLR#(3\6\ /YA7= M\.UQPE*^V$5W'L;H4YM0#V4,N5RY+I:M%D[#.
MG,ZO#9/DC))7 ^S<2:W,;6#D)0*YZ$8H_S.6!$P"N1$OR2U
MAQ8I%/-9J+C-XNV[V&XDMFW : ,8;O>_ ,(!S&WMY_U ,CME!C0="
MOEZBFEZ(=X@E\TOQY%%#-.:3P
M5*\4B^0$M?WR2OFE466NSO^X>/X'%W WG)]"5XM]A<4^$Y,4=%Y:WVA$'\$XDKK( PR!+5ES7!
MSD?P-ZER:7.A@MRB8]F'($N@YD'
M1\ :T8G,!&>?CKOA
MMCYV+6I3SQ$3TG1 ,9?C0W J/84FU2QH-C2)#M=V@+'^2JM[)@W!752_K==O
M.F@JXI;@;2% D((U0=6A
MCN%;<2(S:N21]\#@&5S=Q$0^^!*41D*WYA^^]+!?B1E81H5*G@9-^3;U38[H
M!G 30#F.#7B(" 6?E-)0K "8CC>Q$3E@3!E0=@=N'
MI_6+.O:K7YXM/"HK4N:?5F(")1\3=0= U&9B'&?A\NZ("959AG**WL6 =[E'
M*I5L 8$Z3FR7M[K+:WV]/AX]]RN5Z,/WW>4I>NI8191'\&(+,8/B^N6C4[]2\"82C:O
M9U,666=;.U94M I2@V$^-)IWS5KC[C&X:^I+O=F)[GCZU/C0Z+2S9)M0XQ +
MA^!<=T^3GLKTYS- PX."AH?836K8\&S"DF!D.<
M LH^D7$5)H;]+@!CXGD2'1-%:R!RV;# <59+V9:B',-*YCD1C [H"[CAC-G$
M=X.A 7J&!C+PLP/;AXV \G6=%W:&FXU3H5=7?6(I=@+./8^/=T)=? 9V#Q['
M-Q9F5SD:YQ$WS;9
M0KID]VK8>_&-MY!NO/TS,A8I.P,VL@D;[ 4@T6VRP2V]6M=RC&][WTL1"NQU
M5T!XTG2RN^Q,7+K_Z*_'SIE8(FF%I\J2 @F+@ACM+,&2%,;.%$\/.A7>^"CH
MHF^4NE$:T?M0$A4DVRD)+MDU@RN@3#:N5/3LP(/FONXC#'JW[[/VG9Q\#>SY
MZ76.+I6XOXITZ_G2086[!FZ1(,\P0I!%@!AJJ".)]]1#!QJSM 2[Z5L38E!?*O3@,CR*A]UT$8KZN*#D!-?"==F
M6CWTX0- -?%O8:@*"#N^#>^HYF"R!HZ @9DK7?QE?-J*+WCI9'QK99@\"'->
M^_/OK\/L]/&_\K#8^7+A.>_Z#V]$>9O=8Y\
M[F;&UYA&E*)5ME&5?T_&,7/[85+=PY&%5]W7HZ?$ O/K0UM"0$[FR!?J 2:-
M2#M+/C%P <2;'_M)XPJ>KS@4QU-&?.31JBW_AQINF]D\8S#& S#UMCI9(P
MX[&M5JO5^G6KU;W__?:W\X/][Z>')P>;&_NW9[?GIP>G_[MCV[OR_I?L*US_
MDM^ ]H\N3_Z#CGX]OCR_O/ZZ]I>L(4/O?>?!\Y_W;KT'$J,+\H2NPP_GP"[
M3M#5]27Z=GG]VR$ZOKPX.;VX@6OPZ>;R_.SDD-[P[>SB\.+X[/ ](](_@+A[^8F"D2(J$T<4%1F>!
MNXNVDP%!__A)ULQ?CL.'H1,\TR_6+Y^1"U]]DI >HK?$CD]0V$=>$B/?Z\,%
MUR.!"\W=I;$7D#@NO^JRA7!78GC(]>)!T!+$'L]$CGL%B##&0ZC\(?W $_[S^AG4S=W
ME:R+P @?;MI%AP%R>CWV4G@-F0$O*S*4T\"&/PC.X(
MO=&Y@S[#+;1?.7-0+XV\X)Y=>H9W(A+TZ/<3XI*'$9M5F?%9Q9L;7A^Y)$H<
M+T!#$D&W8%Q@=%WS^S%$]Q#!?/@IRA,[P>SVU)V
M$96NV=-R.Y :,%;XSA(AVWT/=Z#KWCSO%9W^,!
M(0ER@DRP9KP!O?*".($_=/1B.GSA,)>'C(D@'1[E83\*'S![>SP(4[]'QS(B
M3@_!",#;_DP#EPG1DYG!X7TQ(N_N9$[B![MSQ2%O0-M$?_DSH1
MZ$.8^F08D[Y14-#S=J=-C2N-A>I_&27:OF=V:
M"?]*5>LKTO^:[,Z4K('S2$ ^">B&B Q!BGOHWGND^H3T^\1-"N53*-^2T-$Q
M,WZ)F:[8W'BI+$K*^#9R@MAA4E^,M!,C+WM=Z4C.%X9+-6
MB\7NYG^"_AP3T".Q&WEW&05T/"@53#*IF&N^=0SN6#H$"+V"ORZ2._AS'Z,/_3"00S#'-$30X/IIC_%^=!&7F(9?S,*$B@J5
M*-"SN5538F4N!53T[4V_'#\"^8E1E 8 M/K@S 4@E&TY6@*T#9U&0K Y;/7]\8F4;ZJ
M/H%V!.E(W0%=Z+(>P#,X)SN[D G/Y+4G,.XFKY ?0UB^)Z\YT*KK#8&PR>O
MM<0+TJFK)$Z8 3IY%8;WS_&+-S>RJW?$IR;>U*VP4N878(1B#Z2'XOP?5"/$
MV:)V,^82&\U"5Z/PCK8",P#&G;X'_L [[D/'!U7@QR$;]]=YG@_+&W> F#V&
M/LRPR(O_RA8 ,)TR4Y8.>RYNF=8IU L=OYX'P"C:W*"LB3PVK#E2"6,F@-
M4)R,!_0RB UP#*C[16J2HM9"G,KPQS.N7\.3Z!L0
M'D:Y0Z)8]Z:4R$P##FR,CUAP?2^F]F4%0XX96S/IF6%^5;P'MY 36,O6P%&SA+7=[R'.$>C@"/QCO6[(D?1I1>GQZ<7MZW5K/=]GM/((-5X"DOC'4G]]7UR>LVNYS1D5W9 9,X/KVY.
M]XH/;W9\FDLO&$&EBI%X?9!_."D(,91/P*@OMR?C7_Z=/YUU=43RZ,;LMKPG[SF/H==#E<6!Z=S9--+IL2^D_M7[$ @M3 &XH$Q+8M$O6&)AM2LFD[PKT;6":0[TD\3^8>25
MUU"X2:EGPM/*>O.7<2TU]@QLJA.KJ1[
MEQ06E_HQ6BIH/WGMU 7U.W%%,;"=,CSC?'7"F1X:+QGC[?F?7)>0?G]K8=J)
M+5;3%,&"NU5>EM'D0HQFPH3\$H5$C!\4IY5=)#O%Q5I^$@8@8E((ZM4BM..;
M[_CH;\VW+5I=0*O+0 #+F6/JPN98X6UWV$3;$[.L0_+>_"SC;6W3%S?O:!@3
M=4*Q>";JZGET_ R4+68&_OP6QID,J4.6@@U;+S]P'5\K!\'?*V907+
MNE6!O,\+P'^U&"=K6+'L!3)N/N@ZQ;=!&UEF:=A2C'HLXV=A7IR".'3=,*4^
MY(BX!)3#G4\P"DBR*/U05YID2<>&(:]42=26>-7$JBDM2^PK]W?VC5/$_N,G
M69=_>8T52]0CS6"&NF-I6%BQ:XJ;@!94#RVB
M6%A2:@H\>&WOW!C8$.V%_)XU)?KZL.&;6+&(Q
M32PK+=^.4FA@Q-+PBM!!*]1!NH(56P"9#RBE7\.P1\]F-^9&M@VL&2WW(U%Y[MO,7E.,AB9Q:+N&H<>97I9@"6Y.6:=7,0N&VH-M;5
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MT;1@4%%WQ*RV!\(K(@A^+52#(0BX[#)L+C95JKO#
MO7+%@0U9G)Y9!]6A8:UN(+3 'B]S/[9 ;:@*5HR:9ZY7K3=T;%?*H"_T1MOU
MAF)@5:KI.YL!.3B)P^(KZ%7PJ;TQ6!WA4#-*K#/CPH_QMJP$D"T 7+)J8DM?
M;5![;<0%-$J5G(L"A+%&=<=)$:I)-Y5:H#I,%1MU:SO5)'%-
MIF9]$]/ 5J5,=XUDO=V^:RME,O"M4N4X+F'(XE3)^<3N$DNU1/W([J1KN;$=
M:QA&6V^Y%\BRJBQBS5)XYU(P2Z\RX\&SP+7HKJP70"Y"7
M:F--:GFXH:%CLY)KH1F?C*EI6*V4W6HA]/&!LU3%!J;,'R'44F6PN&0%-X2>
MBT1'R V#1Q(E+)'_09:2PZ
M\V/\,BL1R;,2-:-7=!-;]B*3&BYC(]FD:26J;*4U@CI,W0B%Q>, C;/WKI\<0>_>!L9IE'AZI?;PZ/STS(%
M)0)DI82&R@34P3V%_G:8$3N![@J;.@3V^D 9&[J$!(T&6T
M/YS1*4KPBRZA18"H_2?G.=ZB _\=5M*S_X,^J5O%*YEW=.\GF_VS
MA?XX.[G]_G5+EJ1/(TJ/3R]N3Z^WN6M,6^7QV>G!3?)T3CZ/+ZY/2:7Y\SJ;*W @7@2S#S( +RK2 %MW-
M5^=\CC$'23+M( &JRRIH_^CZX+L'5G_DN8Y/OUU<8%C7W-UJ9,_G&5]8E\Z]
M?JZA;ER/!"Z):5>.TM@+2!RSKMQ%],;#WI]I5G$ZYJJ#+,"ZU(_1TD+[R6NG
M&/CBBN(QVZM3G0/>8@GI\&;P!4EH'N[%A9O52J&N2U@V%AGFO]#]2EDWL*:)
M;+IMM,YK^5QM%9N5&48$+&R6))-N
M2S@/]-CA?[,+\2!\@O^3H0/V$O&?T1WQPZ?/C27:-4QLJ(LLYKY8Q2+96%Y>
M0@*A6%8XF+)N85WJT!GG14:Y^KX7W&-T3P(2T6K$5*WT'KP K!_J=P'-0WX,
MJ9.F*46BZ=BJ&["\0CVB84EI;]X$&:OZTC("STV=VU;*5 EK:LT@OBZBE9.W
M$$EC"L/ JM5:A:$ $)8$[E@'W*$HV*B4,T? CBF]\6L8]IX\WT?>P]#QH@>6
M^: A.T6UL;'0H/^V0I4T9EP#)#1"6=*DQ
M4(%EMDQ>&N/+:KMM^&,>?43\*'PKX%0:-94'95G05ZVIKW9>TT("LM_6H;U7/+[\Z
MJKXM+>M84NK:TEVTP,YH%!")DZ;W?E2:8:BM,TS5VNMDUK%L+RW7[MSDD;92
M)DO85N9(0L ;@EBTSZ8-GAI%;:LS5]&719GPU*S24V-WYK0L7[:F>S(*/P)2-]+X,D(>=D-B?.CN5RUVXIE8[U2L?*&O#0&UK76
M0D*C(N_X55'UW33 %$VO&R(ES#"J,HYR[; ]C,)'+_;"X'-K-(5L85MOJ\O$
MP*K15D?3MHYUG$:-^8"-A=9-7 .O":=D\XE&:DN?+;E%N?^
MH0E"1XQ"_>XFUDWM&E8YST_?3LU^^W
M7[>L2>:.+X^SBFDMO(4?]]Y"<>21$WLN-=/J*H:?
MYZ5YH2#YQ/-3.JL%3!:MM@ FMWOF"5 L0#&WK:X2%/.VI J8+& R;ZVN#"9O
MOE.@3=%$@;95%FA318&VAAL4GRK,M%4LLM#P;FEF9C>/J95E)-NB J,76",7 =LIP
M48Z-QW)LEF96//JZ",.TKMFTK>HV-M6EY95:]L&FSAQRJB%QFF5B4YZC=E)7
MU,+:%&8S-!D;KLM5ZI.YBJ+6'#FB.K>7=1" >%V61)
MQ8K2VJ0)JH;52O4GA1YINQXQ+&S9(I$#G^78;!E;VK)2.,RM)30#T(;0$NN@
M)30-M(1(WOL!O7%- %.D;I)&=&^1*@XO2,A]MJW3BJ2^VY4.\W9ICG)*-I^J
MI;[X=1%^O%*W#6UG.:4^-ZI!K$I17,VX/ 3^6 '9@%OS^FTVMJSV;C.96+,$[FJC[JIOG)E8M^?)%]YN-;%^
M9=UT6CBQK9G :Y?W6:VS6FUO(O VEW4SY3F*-O$&+!9\.)/Y@*E')_7B01'V
MWR-W"7,5[W^[O+@=G688> G9B8>.2_:"\"ERH"=/$;T6]OO[7^BM!\73FQM>
M'*=.X!+DAG'2&$Y1L5)WGY9;[()#@D-\:J_.C L_QEP'RDW2L)<5[B;7H4R1
ML&2NS%:J09EJ8T5;[P2WM1>4>7
MKF5]2=Y\>J+B) F,X\M+J*X>=G81;5);D06M'J!R!Q=U=3 9*Y%V3.6ETA2.[*
M)!:0N'O3:,TA\>8[M259?;HEE,\3M25GLT83M247)F-K7UO2$K4EB]J2BJ@M
MV9*7+0,8BMJ22\42"ZTMF36WS@4FLV9%EU%GDJ\ZDZ8I84-OZ_'(
M;46SL%SI.)W(6M-B9Y:N*%BS:D8A=]&;M3:U)77+QO+2#DS.K5=DT\2:7=>_
M*O1**_UL,CT;.8=RZ2[RX*"VI*UBW6IM:4E%PK8BU,@ZJ!%3 2 \?]V6M=<9
MA^[?J1=[#'1$Q&>N6I:U%S&T0AVC;$\];K]NT;%EMA:BZ-@TA.&S#II%ED3&
M\76I86O*6&YOQB;%PK(DZF.N@]+05"PI HZ\JR5^#>D^?[R'L8.EY$7?Z-
MI8BR%*QK-5,SK_OLXY1L/I7&AR10H T^*E\K@#Q:NU$C8TT5Q07608<8=4OU
M=1%UO%+@NE']8&"IM5463759FDOHAE7J!FPMP";A)'<27XGJ/BP#@D."0WQJ
MK\Z,"\\6VH)+C[2DHO6V;-K8,JH$'323'%_6L5QIVUP89&T'7=NRK6-)$X=!
MWU<1;2EK;619#3RJK7:J6T_$U,54
M.S$5UMP*4K D"]=S*]U3PH$G."1JT8=&UL;5UIZHJVI:6=
MD9J7/%/!BKHJ5QT?4&M;D?2*)RJ[[G!N2A34P[%5N5#BHTMGE6
MNTC8"IT[_;;ZH6$ATN8PTG@#&$NJ?>V/-KI;4?EZ6]:P:B\-7W#J1>&4;$X1
MR8=$4/A_6FZ["PX)#O&IP#HS+OP8=5VH?TU=/;:U,E]*K4(5"I:E*CMMJZ9,
M-[%4*5"37VU42X1D"TN5,ABL!Y3BK3YN$TN2X)'@$;^ BK>1>4>7B@K8ZP8F
M105LT6IKROVU>]YUJ[B?M5NI/I0H[L=%JW5&WMBUYC'!>%M..U'N3Y6Q8:XJ
M-6"7)E8SK:YB^/E9F$4%;"Z$5K3Z 4C]V.TL(A2V*ND&-A.&2X*8?-8"-N0;6S:;3TN
MN6U;6%66=B11'&9:C4M+5V2LU0U&[J)/:VWJ8&N&A#5Y5>'GM=6*H6&[4CY0
MH59:[VRS== M-7.=B6TP3LI@FQJ6Y=8F3+"P+BTM%[K0(BL<2D/'QCSE:KNB
M,M:H"K:J+0N>0Y3IRM:HOU%;55K6?J"TPG)*=E\ZI':TB? 1UNKWZKZL@H0[TY%F66'R;'IO\
MW)9JN*J,3:O*(:VF_#ZFM;3,= )FK7 L90O;MMCBYK@RKJY@J=)D;$)5Z*W=
M8%^:F#-:&_M
MJ?NV4J9C0ZDIBP+(9!O?D?>8QN-=WVLMKK,C9D+-O+NBJ=;FJMNFC76MK1M<6>P(1W(YA.1?$#^A.^GY7:[X)#@$)_:JS/C
MPH])M]"J,&MK@X?=V42
MMQL-F_JJ@D^[-(NX0WIS?H
M]A+]?G'X^\G9[>D)NKJ^1-\NKW\[1,>7%R>G%S=P#3[=7)Z?G1S2&[Z=71Q>
M')\=GJ.S"W;C[=GE14-EM[?/WBXC[(V%_O-[)"YD'A?%60$N(+K/$M/XZ2M8
M 8'F++'\C/K?)2*,5V@HK];:IYHTW0[(YL9@5*N8HNNQANB/-$1<5%2/T0"6
M;W1'2( <5B&7T.3XK,#Y$#0.XRE]2ZYQWG\?**U[5LVGWR=N0K^.WT,>LUL&
M3H+HF&W+>41.SXO@9O\9.4D2>7=IXM"-37B6TG$;.4'LN)2E&&TK^2-]N)(Z
MOO^\N1&GPV$89D4J]*?8$!'=LDF"5%?=$
M1XQV:^(M>1__\9.L&;_$I9?25EE-J,V-,*(#D/K3W$1/8>KW2M(WR#;0, N@LZ"S/AQ"#Q[9M3?$93&I)_Z5(J'\*SGLMSL
M]/%^2D\QS**3B%(TG8BMEI=
M,Y:OS8T)T1AW9LGFQH@/#KOC
MGVF0EZ57)8P428'_T\4!?NV'OA\^Q7O3DEWJN3)&KZ^"V0GP2@T""O'1\>DY
M#1LY/KOX]>N6M,6^7QV>G!3?6:20ZV]1-K"AK6PQJ
M<>-\ ;K/B6,"RRNL5[U7M5!C"15T4\6F7J4BSVL'X+L[B8\I7@S<9Y10&.GG
M=0&98=DEG%Y6F'FEHP/]N/.@.T_[EF[TGLF(+415-AT+LV/8$^HI>4S(C
D'8?Y9WM4DIA!>][$2>F)EZ6+TPHK[@EY9KMX51
M;:$P_AXSF8&1S-RMKA>!$4K#9*AP.(^.YV>[5R.?*76C9Y^]&&56;8*N"=WG
MHEB+1@+DI4@V-]XH1F+M_ L7=4A*VQBY7YVZX.D48&V78=RK$K0"-[JZ6XIU
M.!R9[LVYS3,O-)NQL 3U2.Q&WG!BV]EYL2HR),C[LT.9]
M4L\PD\<>[;=FO-/"&7^=[6O%;.@=$"!WM*\UL?DRVLHJJWJV:4X :X"=!O/<
M#^$GE(*U%I4G2YUVXP:>->X^PL. 9CZ"I)XJE$501
MBDE %Y:8N"F%62,"$-M,A[^E^#ZZ" 6N-Z0;/]F>#^W?S[JB3J]E;VSUT'(E
M0 ^=,_">BNUM;I0;5'1Y5ZW>8.]E-R/R&/I@H-;HI:'LZM7:S)#H["%P[B/"
M^H[IXPY\ZF4;:X?I/6B2[$6*DA-/]Y;_3CT:9@DR-2E)V_!\C_0!9O30W7.V
M6S_5QN=7Q0W +L 1WR/,'^[DXE?@9(9M7I,+RD]ZP\Q1S$'X#/U(6V5%M4:R
METSJVFP+?(\:@*^ &>[BV6UVP\]V:X16L&TG[OCMZ
ME%%!F69CT9$I?PIU\233GE1 =(=QUEC8WS^Z/IA0C;EJ8SLJ1U4CA,5V=7D;
MQDU[>L#D%Z?1HI1M??![#Q
M2F%0V2+9BM*1LH+U2JG^U\)?+G:E^)M(5V\@S294H&&96+/KIIKG=\ZLSQZ3
M\,B\[72Y:Z7399B=O\B,26H>@T5,HFR_J"B*@7S/N%K=>"\6-.L+2T7'.#Q]#HB??V#;FC-WO[. )"-;F1JTC
M$K=TDVGJ78785CWIE&V4LLD4997*QH=7R3K3LT/G$RK[T$SA0Q,^-&$MOK06JQN+
M'7>7C6-/68@8+$23*YOKARS@8F(U:,QIIF&E;B(AX&WM>A76-K"@F;J%#6G^!8V322.B2=C!G_FC2A\#WG@$E-3M$AQ
MV74 :HNZRUZ$-+T3'#<50&U*TNY4(#_\ZU&.C*+HWG8)O."01R/\F4)DN!3C(OPV'/QLVSORB_"R9U7MYDS3XL##3^0B>[D
M_P8]&^2^I5.J5I@/Z2ZB-\U*A_"F@VE&_Q;J1).E.;O]'ZH]3V=KS[K.LS8)
MUNK]D:#Y[1HMDD%IP2G!*=$D )O00K]5@8I3)S0*@#^@1D*"]5DB9A](RB/#F6(G]BN^/9J1NZ+Y&E=Z&N?IS5
MXE#UXA:Z/SYUWFLY;IBS5!
M8RA>0,EL]SSK+4T\3?L>C=)^E0Y6]),\\4\Y[*!43H2%2; 2+5Z\N3$.6*A]
M?F)V79BI8(ZL40:/@> _T\B+69&5,'CUI)R8M)4G[7W[)ZT?QC'=5 &;"R9H
MZL6#B< 7*O4?F4Z;&^_-I]+L93\_A#U612D,L94816I,')TT'\LS(G%5*R)6G>YH9%R-.C,X[$0;MG@CDQ1&$F8'EJ\\X5RT5I(FHM\V--],P^WOYT?
M_#]02P,$% @ X())42ME!%V;"0 +PH !D !G.30X-34Q9S$P,#@R
M,C0S,C Q.30N:G!GG=%I/-2+&@?P_]C&,M+8C6%.)LL8*EN38RN[.L@Z&%EJ
M0KBADJ'1G!,RD89$B3B%+%DN1MG7%%HTT=C)*(XE&=N,D?G?.G=[W_/
MR^?Y/)_/]WG $? CL/>XK8,M (% @(#O!8#C@!4@*B("%1$6A4*A8F*BXC!9
M29B$!$Q)6D9*5@6!4E5!()$_[3^@^9.:#AJ)U,)A= [I&1H:HC2-S8[HFQXP
M,-3_L00B)B8&DX I2DHJZN]#[M/_GP-V '!1P!?P%82H 0)PB" < CX'4
M$8;\&> ?@0@("@F+0$7%Q"6^#]3O!00@@H("0H+"PD)"W[OQW_N $%Q8>I_>
M,1$9ET"H6I2L_F\9#T71EC6=6U=?3ZI\\:&INZNI_WO'C9V]?_?G#H W-X9'1L
MAC7[Z?/*P]^'G?YJF'C*4E;(*"]+-R7)HQ&S!3($9%6U"6WE53)TO7(2Q[+[BM_!.Y^<7E\_32Z#MOV,S]H@50IEVFIW $V!L7\LZ*[4^Y9M/
M,+UJ#6>AT* 8R]#0/[)3?DDXX>KEH6MWTM%\J+__5)\$,NS#R(9 E:?N7_E#
MS,_-Y_^RW)WS_5%U$SYV?$CG^1=5&]F-YIP?4&SNC54K/[MR:"YUB*UKX-["^.JZUA5SG;A2KOK6(YA49@!'@,N_Y$$'AEO]MJ0PIAM25R Q&X7W5J4V(4H.C2"5+YR])2
MC*$3I&\@RZ NC6F-MX55Z"O&R/)Z&!ROR8D%QTRDU^W)]H6O)O6$_@JP"D8UO^PQP_;P=4A6R\\L5M-'[7;*[!6.0R?/O^%RJ@F9;D]I
M'C3'6* A&ZV-X:M#18I:Z=?X_01"HA2LW&6((T(O]'1_7!3LEQ?:^?QCFR0(
M]!9'@8"_X[>D!=VF7?)AI854A'$3T^SF,&\!Q&Z%%AAETC#F^39ZY1Q]_
MN--+3"=>"FSX2"NM*L_:+1:&-AECWFU%3Q36'0S5V>*UY1[:N6UR% 2HO;LV
MH4QGZE5"&$[%L2OO#@@A]MIO7"^/,X)"*M4?"U8H9!OT64WREV
M'=^2A]^-I,Q[^4M^\R*;5*:&)?;\5:C466*C>9+I)W2+EV"P/
M/(S$IG)+_GYU]H^KU[HJ'1/:>V58F7V";WV#LL1"[6T6ZKKC-FU445%3083AF]LI_ 6WUD:M.O]U)X'ET^Z%6"WO:
M1YN2MU26[]4WAG>\)CF8F2=O#S]C*J8G_6$Q_0BMK#WO&N4=[DP^:P]H@JZY#-2D=^'L+O<51/M]:FVF89_9CFN
M9UP 4V;]?.9[P(C9;5# C]8Y66BEOW#_,D5!XG%-GUYAW^G.-LC)KQBQW/
MW]S 4TT/"FU=M-QZ//]+>O:5Z)U5'&>6_ZB%XKMJQL^KC@F@T"^M4IC6YJ3=
M!W$)?F]EX'ML)&G*"LD%)OGS-C,@D'I[P<=0'L>4BMF/#KEC+V(7/F2NS2U0
MN&&(&[S[RVV!]^BO^H)I%5+%L8R/Z;:BBV88;$2YR]R:]CM'YWA,PK;*2T
M49^1^^I0F3FQ L,*]?"M=LE-2>],J#(:GM;$LB3D@T#)?/3-6_5[<9UVY
MVKBX\P44$' $#CELW\(^R)W)SO9/0[O3QK!%@;P,OSH'PDNX*_:B6&!9WW+L
M7ZJ['?64T9;-Z2 P^.&CQ/:!L+)!L@;S7*U"CE:=1W^87YPOZF\J%,:;)HY$GITY5)C774K1^EP)'_P902P,$
M% @ X())41B\\B%C P '@P !$ !N;F)R+3(P,C Q,# V+GAS9+U6
MWV_;-A!^+]#_X::G#9A$*6F:68A3=$L#!$BSPDV'O14T13O$*%(CJ23^[W>D
M))MV;,])AN4E-.^^N^]^4F'FL)]]Q8H=4X*;(\ :Z8KH2:CY/6IM0R(9(/
MYV_?G/V0IG!Q>74#*=PYU]B2D(>'AZR:"66U;!U:L!G3-8$T'?1_N_T&?W36
M2YAPR:GED)_-H*697^1WZ:GV9',-@EM1\QBKFX41\SL'/[*?@B^XT$IQ*?D"+H6BB@DJX>M ^6>X
M4BR#CU+"Q,,L\K3")1'TWW%/,%@)+[%+X(S::0 -$LQ/,4KS(CTN8E]J
M:M:AR]]1/2"2-M*]CVD%'@0RZB
MD*ES1DQ;QR^UJ2_XC+82_;3J[Y9*,1.\"EK8Y#57;DUG7:\W"5.W)OO^5#D5+_55:
M'&'\&1I+0&VEO*/B0%Y-9.B%%Q%9-M+!1.RNMO>'=-7_NSCL&YD79V-S*?A<
MC'PNBO+)4OD/F&AU\UHRT69\#J&M(^H/Z6I6#RK/QGB_O$<4%2PLW]/N
MZ(F6>#E^ 5"Y-.W;4;7?47R*M9P?O_=RB!OC#M\G5CH=K^7(11Q^UTO6B8WBA6>M?QN'_1U5]
M4LAK<85M9>K *0&!3]P$U;\?I+YD.'"L.'Z.BM"[2 '_\&MUL! ?J:J@,P>1
MO3.R:633?FMY];LZ#V=&)6OE,N,]N-?8!]RLU>'(%;/=N/YVJ-8PPV1SB/N;
M>-B[JV[9X,]_ %!+ P04 " #@@DE1^J 9+90& 61P %0 &YN8G(M
M,C R,#$P,#9?;&%B+GAM;,U^[RTM,24N*-(>E'^+0Y,PY&[M\.WO\#M
M%9RY*F12P)C/6387%VO)I[,0?O)^CKC@%(5@0DZ%9,/S.\FJ $7_P[-CXFI'EZ_ M"[4:AHW7''[(QD7ZPF,NBB
MG.IB^X>]-*7SE+':27D\C!(&1T='O6AK-EIQ6ZP&'_3^O+J\\V9L[CIZ]^N/
MRTMH%!^J:/TE>M$^+%$@Y$:8WYPTS#&KG,&!%ZH>/9*F3"9PGR=VSTDJB99/]ZML(M>M/)BJ4KA=NL@9F1Z%,5T92CCN6I-YF62;N
M1'H;6*[T4AR]N&CQ$R_)UB__.A]\3]4DK5@T2QRZKU4ACS
M3(0\7']A4V[H1'CMSEE9?]IS6[)IH1#,CZECVGP\(N_&!/#$ (:BMH.;JSMK
MY*K%4]CY9*XGN/X7G@?NM*R/MY):,K"]=+1LK&-9"Q"15[\C@X&N[=$&"LV:
MLVRU=#-VI,FD&USH(XS5;VQ=;WU3'M+@Z15U-@,,BU#4I?
M9M:7)6NE-.,MDQS],^&?ZI/WJJ[<2F[9GG8I6!!$85@+(+5S8PK0'&!(R$S<
M0.E6-Y>NG^[PX4)X*!%23_OU"/V*9VQ[H%H]M"@G$TNGU#_L
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M?/,P7H+M\X39O+\52]8 5MR&NB ^]],&2MEH6Z$1*47]4$$/>5/>8QN)VAJ'AY
M<3>O)5OF"D#[]CKVM&,1630"APB=Z@)+,_5FK5JE: J[WC%O*75[# XF8QX&
MI2?H;EY+=LT5@/;M=>QJQR*R:PH.&ATB^-IV;:;>K%VK%$UAU[%TS8L"=^OY
M!(.R7MU*:LFH]M+1LK&.12U 1/Y,D"&&KNW-!@K-&K-LM90S]&SES;1F5N7Y
M:7MNR[/4*@3S8RAFZBX>]5Q-&6B>GVZN;NM\+5D\A9W_T(0A$R.9$9CP#T>ZJ^$*U?7
MPMW21P^VS+;F_NE"$T)*92XC"?9%US+T/ET(;3\0,+NKO1F9Y #6.G9DAP+_?HX#
M'A$(7>CNK.)>E.#X/7Y]'L?$3JX^+1-.GD%I)D7;"VMUCX"(9,S$M.W-M4]U
MQ)A'=$9%3+D4T/96H+U/UV_?7/WD^^3FKO=(?#++LE2W@F"Q6-3B"1-:\GF&
M(74MDDE ?-_6[XZ^D-_7S;7( #A0#:11;]3]"_+KG/&X9;[4+^N7M5OD
M1@H!G,.*W#%!1<0H)T-K^3WIB:A&.IR3@9%I]*E!/4-DVJ*=NMG@15YVYKEGFAQEDO"9K,9Y&>+]34K
MJXT-A,&?#_?#: 8)]1$"0HMVFD(W9=O6WN(EB?M/4U:^D\TKV,\MP?T2UR
ML(;YYMMJOBGRPX9_%M:6.O:N39/KK"K)80 38CZ_#'J%-H5@",8,J)Q]6*]_
M"#*ZE$(FJ\ (@AL9S1,0F?WLB/A69"Q;]<1$JB3OAD?RC+9F"B9M3XBQ\FTT
M8^;= -]/250MDKQJM L23EX)-CJ3*IPX(@LKWV/!04!+#,0,<0VC.G C^CN
M]9KG9M#*J-!]>]WFL#1$M:E\#F)@V&+8- >^.?#KX0;5.RSZVI4X873&.E,T
MRHI9X&:L2&4+.1T#;WLEHN"_M[7N^@"FS#0BLD>:P+'NRK5%D]LT.RHJ1*8J
MLE'Q< ]E\5K8U A2JC">'\UPVK/JB9)):<3H]%
MMB.J+JL=HQ;2F6.0UD.NB_U0E/=PYEK^!JO3KJ\]<76A'3!LX9T[!L_^0HPP
MF<8J*A*^:/3F*^8QP>Y\D8U&E,MW55![CM
MU=)J.DEK1)>]&)/!)FR]C'T-NH-!JL[QH/$-U+.ZDU [<8RIUIL/7%I#>!K0
MT@!5AUEJVH(,70;9QM67.J/\+Y:>?OM:'L$1FCNN+4O7EOQFANDHH*?0
M*VJJRZOHTQ*Z;#"^S,I3EQ.[.NJ2VK?JZ7EV@;-$**Y,1HVQB.6\:.O
MJ7U==6GM>[6T7-N1&2EJGF$/5\E8\F-1[8BJRVG'J(7DVGZ*'6ZWRVA&Q11.
M>6)7KJTNLG*_EIQK>RM_H,L,1%@.B*O+[H#A#;QSU_90AI*S
MB&4X@3S@ND4Q>O0$6::L+K8RMY:9:]LE?05F^ $N+_-G7>;5$?4TF1Q_U_A2
MA.HR?,FU9>G:OLE.GWI:ST']>Z(E<9SA6N+=TG5S#^4V 37%F>>SDHMLAEU-
MJ3CQ;8D#(:K+]$7;%J=KVRC?W]ZY 1TIENZ_^7?$*TH%;74!EONUY/Z'[96K
M8"\G]UA@WKE=GS'_S!ND6/(-4$L! A0#% @ X())46+],GT;$ X&D
M \ ( ! &0Y-#@U-3%D.&MA+FAT;5!+ 0(4 Q0 (
M .""25%$/09*FRH " 3 P 1 " 4@0 !D.30X-34Q9&5X
M.3DQ+FAT;5!+ 0(4 Q0 ( .""25$K901=FPD "\* 9
M " 1([ !G.30X-34Q9S$P,#@R,C0S,C Q.30N:G!G4$L! A0#% @
MX())41B\\B%C P '@P !$ ( !Y$0 &YN8G(M,C R,#$P
M,#8N>'-D4$L! A0#% @ X())4?J@&2V4!@ %D< !4
M ( !=D@ &YN8G(M,C R,#$P,#9?;&%B+GAM;%!+ 0(4 Q0 ( .""25%M
M75@9U00 +LL 5 " 3U/ !N;F)R+3(P,C Q,# V7W!R
;92YX;6Q02P4& 8 !@"( 0 150
end
1万+
被折叠的 条评论
为什么被折叠?
到【灌水乐园】发言
